---
title: "ACM Research's $2.5 Billion Backlog Comes With Fine Print and an October 28 Test"
description: "ACM Shanghai's backlog hit RMB 17.1 billion ($2.5 billion), up 88.2%, posted to the Shanghai Stock Exchange first and furnished to the SEC second. The company's own October 28 preliminary results will show how much becomes revenue."
publisher: "The Inference"
section: "Chips"
published: 2026-09-30T19:35:13.344Z
modified: 2026-09-30T19:35:13.344Z
canonical: https://theinference.org/article/acm-research-s-2-5-billion-backlog-comes-with-fine-print-and-an-october-28-test
language: en
keywords: "Semiconductors, China, Earnings, Trade Controls, Markets"
---

# ACM Research's $2.5 Billion Backlog Comes With Fine Print and an October 28 Test

> ACM Shanghai's backlog hit RMB 17.1 billion ($2.5 billion), up 88.2%, posted to the Shanghai Stock Exchange first and furnished to the SEC second. The company's own October 28 preliminary results will show how much becomes revenue.

## Born in Shanghai, furnished in Fremont

[ACM Research](https://theinference.org/markets/companies/acm-research) (ACMR) [filed an 8-K on 30 September 2026](https://www.sec.gov/Archives/edgar/data/1680062/000162828026063896/0001628280-26-063896-index.htm) with a single exhibit: a press release relaying that its operating subsidiary, ACM Research (Shanghai), had [posted backlog data on the Shanghai Stock Exchange website](https://finance.yahoo.com/technology/articles/acm-research-operating-subsidiary-acm-110000435.html) [1]. The order book stood at RMB 17.1 billion, about $2.5 billion, as of 29 September, up 88.2% from the prior year's disclosed figure [2]. A year earlier the same exercise reported RMB 9,071.5 million, itself up 34.1% [3].

The [Nasdaq](https://theinference.org/markets/companies/nasdaq) parent holds 74.6% of the subsidiary, which trades on the STAR Market as 688082 [4]. The order book behind a Fremont-headquartered Nasdaq stock is published first in China.

## What an order book holds when it is not revenue

The release's own fine print does the auditing. Backlog mixes tools already shipped but not yet recognized as revenue under Chinese GAAP with tools not yet shipped; it is defined by neither Chinese nor US GAAP, and orders in it may never produce the revenue estimated [2]. The split between those two piles is not disclosed.

The same fog shows up in reported results. [Second-quarter GAAP net income of $89.0 million](https://www.sec.gov/Archives/edgar/data/1680062/000162828026054581/acmr-q22026xearningsreleas.htm) carried a $69.6 million unrealized gain on the subsidiary's short-term investments, while the company's own non-GAAP figure was $44.5 million [5].

*Chart: **Most of Q2's GAAP profit was an unrealized investment gain** Bar chart comparing ACM Research's Q2 2026 GAAP net income of $89.0 million, the $69.6 million unrealized investment gain inside it, and non-GAAP net income of $44.5 million.*

*Second-quarter 2026 net income measures, USD millions. The unrealized gain on the Shanghai subsidiary's short-term investments sits inside GAAP profit. Source: Q2 2026 earnings release (Exhibit 99.1 to Form 8-K, 7 August 2026). [5]*

## Two camps, one tape

The bulls buy the printed numbers. Revenue was $292.9 million in the second quarter, up 36.0% and the highest of the last eight quarters [5][6], guidance was raised to $1.125 billion to $1.175 billion for 2026, and the company holds $1.0 billion in net cash [5]. BNY Mellon opened a $41.4 million position in the June quarter [7].

*Chart: **The reported line keeps setting records: Q2 2026 revenue of $293M, up 36%** Column chart of ACM Research quarterly revenue across eight quarters from Q3 2024 to Q2 2026, rising from about $204 million to a record $292.9 million.*

*Quarterly revenue, USD millions, eight quarters to Q2 2026, from ACM Research's SEC filings via Sharadar. [6]*

The tape disagrees. [Shares fell 6.5% on 24 September](https://www.thelincolnianonline.com/2026/09/24/acm-research-nasdaqacmr-stock-price-down-6-5-heres-why.html) [8], and the $76.63 last trade sits under the 50-day line while every published price target, from $100 at Craig Hallum to $136 at Daiwa, stands 30% to 77% above it [7].

*Chart: **Every published price target sits at least 30% above the tape** Bar chart ranking ACMR price targets from Craig Hallum at $100 up to Daiwa at $136 against the 29 September 2026 last trade of $76.63.*

*ACMR analyst price targets versus the 29 September 2026 last trade; targets are analyst estimates, not reported figures. [7]*

## A CEO sale, a lawsuit and a slot on the Entity List

The credibility ledger runs longer. CEO David Wang sold 70,000 shares for $5.22 million on 9 September, an 8.02% cut to his position [7]. [A 2021 class action](https://www.newsfilecorp.com/release/72295?lang=fr) alleged revenue was diverted to undisclosed related parties [9]; [the fiscal 2025 10-K](https://www.sec.gov/Archives/edgar/data/1680062/000162828026013231/acmr-20251231.htm) reports ordinary-course matters and names related suppliers Ninebell and Shengyi, through which materials purchases ran $80.1 million in 2025 [4]. Washington put ACM Shanghai and ACM Korea on the BIS Entity List in December 2024, restricting the US-controlled parts and technology the unshipped share of backlog depends on [4].

## The company set its own deadline

ACM reports preliminary nine-month results before the US market open on 28 October, with full third-quarter results in early November [2]. That print is where the backlog either books as revenue or stays a promise. Holders through it benefit if conversion runs on schedule; whoever bought the +88.2% headline pays if the shipped-but-unbooked share proves large. One undisclosed line decides it: the share of RMB 17.1 billion already shipped and waiting to count.

## Takeaway

ACM Shanghai's RMB 17.1 billion backlog is up 88.2% but is defined by no accounting standard and may never fully convert to revenue. The October 28 preliminary print is the first hard test, and the stock already trades 30% or more below every published price target.

## Sources

1. [SEC EDGAR, ACM Research Form 8-K (Items 8.01, 9.01), filed 30 September 2026](https://www.sec.gov/Archives/edgar/data/1680062/000162828026063896/0001628280-26-063896-index.htm)
2. [Yahoo Finance (GlobeNewswire), ACM Research's Operating Subsidiary ACM Research (Shanghai) Provides Backlog Data, 30 September 2026](https://finance.yahoo.com/technology/articles/acm-research-operating-subsidiary-acm-110000435.html)
3. [SEC EDGAR, Exhibit 99.1 to ACM Research 8-K, ACM Shanghai backlog data as of 29 September 2025](https://www.sec.gov/Archives/edgar/data/1680062/000168006225000027/acmr-acmshbacklogdata_929x.htm)
4. [SEC EDGAR, ACM Research Form 10-K for fiscal year 2025, filed 2 March 2026](https://www.sec.gov/Archives/edgar/data/1680062/000162828026013231/acmr-20251231.htm)
5. [SEC EDGAR, Exhibit 99.1 to ACM Research 8-K, second quarter 2026 earnings release, 7 August 2026](https://www.sec.gov/Archives/edgar/data/1680062/000162828026054581/acmr-q22026xearningsreleas.htm)
6. [Sharadar quarterly fundamentals for ACM Research, from SEC filings, retrieved 30 September 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001680062)
7. [MarketBeat, ACM Research (NASDAQ:ACMR) Shares Gap Up - Time to Buy?, 29 September 2026](https://www.marketbeat.com/instant-alerts/price-acm-research-nasdaq-acmr-shares-gap-up-time-to-buy-2026-09-29/)
8. [The Lincolnian Online, ACM Research (NASDAQ:ACMR) Stock Price Down 6.5% - Here's Why, 24 September 2026](https://www.thelincolnianonline.com/2026/09/24/acm-research-nasdaqacmr-stock-price-down-6-5-heres-why.html)
9. [Rosen Law Firm via TMX Newsfile, ACM Research securities class action lead plaintiff deadline, 18 January 2021](https://www.newsfilecorp.com/release/72295?lang=fr)


---

ACM Research's $2.5 Billion Backlog Comes With Fine Print and an October 28 Test — The Inference. Canonical: https://theinference.org/article/acm-research-s-2-5-billion-backlog-comes-with-fine-print-and-an-october-28-test
